https://pharmoniq.com/news/chiesi-acquires-kalvista-rare-disease-expansion PharmoniQ en 2026-05-03T14:10:49.718Z Chiesi Acquires KalVista for $1.9B in Rare Disease Push mergers-acquisitions, rare-disease, hereditary-angioedema, biotech, pharma-deals https://pharmoniq.com/news/va-accelerates-psychedelic-drug-research-access-executive-order PharmoniQ en 2026-05-03T08:47:02.716Z VA Fast-Tracks Psychedelic Research Access Under New Executive Order psychedelics, VA, mental health, PTSD, executive order https://pharmoniq.com/news/fda-approves-auvelity-alzheimers-agitation-breakthrough PharmoniQ en 2026-05-02T14:10:48.935Z FDA Approves Auvelity for Alzheimer's Agitation in Historic Decision FDA approval, Alzheimer's disease, dementia treatment, Auvelity, behavioral health https://pharmoniq.com/news/supplement-industry-sues-fda-rejected-health-claims PharmoniQ en 2026-05-02T08:47:02.751Z Supplement Industry Sues FDA Over Rejected Health Claims FDA, health claims, supplement regulation, lawsuit, DSHEA